Furthermore, we observed reduced miR-181c-5p levels in the frontal lobe of MAPT and C9ORF72 patients, consistent with a study on CSF exosomes reporting decreased miR-181c-5p expression in FTD patients [47]. The gene discussed is MAPT; the disease is frontotemporal dementia.